2Chen Y S, Wong W W, Fung C P, etal. Clinical features and antimicrobial susceptibility trends in Citrobacter freundii bacteremia[J]. J Microbiol Immunol Infect, 2002,35; 109 - 114.
3Nada T, Baba H, Kawamura K, et al. A small outbreak of third generation eephem-resistant Citrobacter freundii infection on a surgieal ward[J]. Jpn J Infect Dis,2204,57; 181 - 182.
4Clinical and laboratory standards institute. Performance standards for susceptibility testing; sixteenth informational supplement[S]. CLSI, 2006:112- 116.
5Barlow M, Hall B G. Origin and evolution of the AmpC-betalaetamases of Citrobacter freundii [J]. Antimiero Agents and Chemother, 2002, 46(5): 1190-1198.
6Abdalhamid B, Pitout J D, Moland E S, etal. Community-onset disease caused by Citrobacter freundii producing a novel CTX-M beta-lactamase, CTX-M-30, in Canada[J]. Antimicrob Agents and Chemother. 2004, 48(11):4435- 4437.
